correction sickle cell disease transgenic mouse models gene therapy
sickle cell disease scd caused single point mutation human beta globin gene results formation abnormal hemoglobin [hbs alpha beta s] designed beta globin gene variant prevents hbs polymerization introduced lentiviral vector optimized transfer hematopoietic stem cells gene expression adult red blood cell lineage long-term expression months achieved without preselection transplanted mice erythroid-specific accumulation antisickling protein % total hemoglobin % circulating red blood cells two mouse scd models berkeley sad inhibition red blood cell dehydration sickling achieved correction hematological parameters splenomegaly prevention characteristic urine concentration defect
